What should be done for an adult patient with ADHD, hypertension, and depression experiencing dizziness and lightheadedness after taking atomoxetine, hydrochlorothiazide, and Wellbutrin (bupropion)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Management of Dizziness and Lightheadedness with Atomoxetine, Hydrochlorothiazide, and Bupropion

Stop the atomoxetine immediately and check orthostatic vital signs (blood pressure and heart rate supine and standing) to assess for orthostatic hypotension, which is the most likely cause of these symptoms given the combination of a diuretic with a norepinephrine reuptake inhibitor. 1

Assess the Cardiovascular Cause

The combination of hydrochlorothiazide (which depletes volume) and atomoxetine (which can cause orthostatic hypotension) creates a high-risk scenario for symptomatic hypotension:

  • Measure orthostatic vital signs immediately: Check blood pressure and heart rate lying down, then after standing for 1-3 minutes. A drop of ≥20 mmHg systolic or ≥10 mmHg diastolic, or symptoms upon standing, confirms orthostatic hypotension. 1

  • Atomoxetine specifically causes orthostatic hypotension and syncope: The FDA label reports 0.2% of patients experience orthostatic hypotension and 0.8% experience syncope, with atomoxetine requiring caution in conditions predisposing to hypotension or abrupt blood pressure changes. 1

  • Volume depletion from hydrochlorothiazide exacerbates this risk: The diuretic effect reduces intravascular volume, making orthostatic symptoms more likely when combined with atomoxetine's cardiovascular effects. 1

Immediate Actions

  • Hold the atomoxetine: Do not continue this medication until cardiovascular stability is confirmed and the medication regimen is adjusted. 1

  • Consider reducing or holding the hydrochlorothiazide: If orthostatic hypotension is confirmed, the diuretic dose may need reduction or temporary discontinuation to restore adequate volume status. 2

  • Maintain the bupropion: While bupropion can cause modest blood pressure increases (+5.9 mmHg systolic), it is less likely to cause hypotension and dizziness compared to the atomoxetine-hydrochlorothiazide interaction. 2, 3

Risk Assessment for Atomoxetine Continuation

This is only the second dose of atomoxetine at 18mg (a low starting dose), yet symptoms have already emerged, suggesting this patient may be particularly sensitive to its cardiovascular effects:

  • Atomoxetine causes dose-dependent cardiovascular effects: In clinical trials, dizziness was a commonly reported adverse effect in adults, along with modest increases in heart rate (mean 7.5 beats/minute in extensive metabolizers, 11 beats/minute in poor metabolizers). 4, 5, 6, 3

  • Poor metabolizers have greater cardiovascular effects: If this patient is a CYP2D6 poor metabolizer, they will have higher atomoxetine levels and more pronounced blood pressure and heart rate changes. 1

  • The combination with a diuretic is particularly problematic: Atomoxetine should be used with caution in conditions predisposing to hypotension, and volume depletion from hydrochlorothiazide creates exactly this scenario. 1

Alternative ADHD Management Strategy

If ADHD treatment is still needed after stabilization, consider switching to a stimulant medication (methylphenidate or amphetamine) rather than restarting atomoxetine, as stimulants are less likely to cause orthostatic hypotension:

  • Stimulants cause modest pressor effects rather than hypotension: Methylphenidate and amphetamines typically increase blood pressure (+4-5 mmHg systolic) and heart rate, making orthostatic hypotension less likely. 3

  • Monitor blood pressure with any ADHD medication: All catecholaminergic ADHD medications require baseline and periodic blood pressure and heart rate monitoring. 3

Critical Monitoring Parameters

Before any medication adjustment:

  • Check for volume depletion signs: Assess mucous membranes, skin turgor, and recent fluid intake/output. 2

  • Review timing of medications: If medications are taken simultaneously, separating administration times may reduce additive hypotensive effects. 2

  • Assess for other contributing factors: Recent illness, inadequate fluid intake, or hot weather can worsen orthostatic symptoms with this medication combination. 1

Common Pitfall to Avoid

Do not simply reduce the atomoxetine dose and continue it with the current diuretic regimen—the orthostatic hypotension risk remains even at lower atomoxetine doses when combined with volume depletion from hydrochlorothiazide. The FDA label explicitly warns about using atomoxetine in conditions predisposing to hypotension. 1

Related Questions

What should be done for an adult or adolescent patient with Attention Deficit Hyperactivity Disorder (ADHD) who experiences dizziness, vomiting, and lightheadedness after their second dose of atomoxetine (18mg)?
Is starting treatment with Atomoxetine a suitable choice for a potential diagnosis of Attention Deficit Hyperactivity Disorder (ADHD)?
What are the recommended non-stimulant (Non-Stimulant) medication options for adults with Attention Deficit Hyperactivity Disorder (ADHD)?
What are suitable ADHD medication options for a patient with a history of increased irritability with previous medications, preferably non-stimulant medications like Atomoxetine (Strattera) or Guanfacine (Intuniv)?
What are attention deficit hyperactivity disorder (ADHD) medications with less risk of abuse?
Can benzodiazepines (BZD) cause urinary retention in an older adult male with a history of Benign Prostatic Hyperplasia (BPH)?
What is the best course of action for a patient with a history of chronic osteomyelitis due to spinal cord infection, now presenting with acute intractable pain and leukocytosis?
Is anticoagulant therapy (anticoagulant medication) needed for an adolescent patient with renal cell carcinoma (kidney cancer) who has undergone excision of a renal mass with renal vein reconstruction?
What are the considerations and potential side effects for a patient with a history of weight loss issues, currently on a reduced-calorie diet and increased physical activity, when increasing their dose of Wegovy (semaglutide) from 1.7 mg weekly to 2.4 mg weekly?
What is the appropriate treatment for a patient with wound swelling following carpal tunnel release surgery, potentially indicating infection, and can Azithromycin be used?
In a patient with hospital-acquired pneumonia (HAP), do you usually try to distinguish between bacterial and viral causes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.